“…BACKGROUND: Visceral organ metastasis is associated with poor survival outcomes in terms of metastasis free- and overall survival in breast carcinomas. Identification of a gene expression profile in tumours that selects a subpopulation of patients that is more likely to develop visceral organ metastases will help elucidate mechanisms for the development of distant metastases and could be of clinical value. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Histologic results confirmed the presence of a parathyroid adenoma in 95,5% of the patients and there were 2 parathyroid carcinomas. Discussion: SS and US are sensitive and specific imaging procedures for the preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. …”
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Pembrolizumab is an immune-checkpoints inhibitor that enhances the immune response against cancer cells and therefore is useful for the treatment of several carcinomas. However, pembrolizumab sometimes perturbs the immune system resulting in various autoimmune neurological complications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…According to the Oncomine database, Sp1 mRNA expression is significantly higher in gastric cancer tissues compared with that in normal tissues (P<0.05), including that of intestinal, diffuse and mixed-type gastric carcinomas (P<0.05). Kaplan-Meier plots show that the expression of Sp1 mRNA is negatively associated with overall and progression-free survival rates of patients with gastric cancer, even when stratified according to expression level (P<0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Fifty-three of the 101 advanced NSCLC cases selected for our study were adenocarcinomas (ADs), and 48 were squamous cell carcinomas (SCCs). Multivariate analyses showed that increased levels of CD8+CD28+ T cells independently predicted favorable overall survival (OS) [hazard ratio (HR): 0.51, 95% confidence interval (CI) 0.30–0.89, P = 0.021] and progression-free survival (PFS) (HR: 0.66, 95% CI 0.37–0.93, P = 0.038) in ADs, but the prediction in SCCs was not statistically significant. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Moreover, chemical constituents from L. ochrophylla show potent cytotoxic activity against colon and rectal carcinomas.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: A total of 20 cancer cell lines (8 breast, 11 colon, and HeLa cervical cancer cell as a positive control for mesenchymal phenotype) and 57 formalin-fixed, paraffin-embedded sections from archived sporadic colorectal carcinomas were included in this study. CNN3 expression analysis by western blot or immunohistochemistry was followed by functional analyses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…As compared to normal breast tissues, the mRNA levels of CGRRF1 are lower in breast carcinomas, especially in HER2-positive and basal-like breast cancers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…At 24 wk, HF-CDAA mice developed signs of cirrhosis with pan-lobular “chicken wire” fibrosis, 10-fold hydroxyproline increase, regenerative nodules, portal hypertension and elevated serum bilirubin and ammonia levels; 80% of mice (8/10) developed multiple glypican-3- and/or glutamine synthetase-positive hepatocellular carcinomas (HCC). High-fat (60%) supplementation of MCD in C57Bl/6J or feeding the HF-CDAA diet fibrosis-prone BALB/cAnNCrl strain failed to result in increased fibrosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In contrast, 14.1% of SBBC patients had carcinomas with a lobular component in either breast based on pathological reports (p < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Colorectal cancer (CRC) is one of the most common carcinomas with high morbidity and mortality worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Results: In the group of 27 GC patients who underwent surgery during the active surveillance, 15 GC had only C cells hyperplasia (CCH) foci and 12 were affected by MTC. These carcinomas were all confined to the thyroid, without any lymph node and distant metastasis. …”
Enlace del recurso
Enlace del recurso

“…Histology identified 12 A thymoma (8%), 38 AB (25.33%), 24 B1 (16%), 50 B2 (33.33%), 19 B3 (12.66%) and 7 carcinomas (4.66%). The mean follow up time was 84.14 months (sd = 61.68 months). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Breast cancer has become one of the most frequently diagnosed carcinomas and the leading cause of cancer deaths. The substantial growth in the number of breast cancer patients has put great pressure on health services. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: The mammalian Notch family ligands delta‐like 3 (DLL3) is reported to be a potential therapeutic target for large cell neuroendocrine carcinomas (LCNEC). The effect of DLL3 expression on LCNEC prognosis has not yet been elucidated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Tissue microarrays (TMAs) were prepared from archival tissue blocks containing 161 patients, which included 91 adenocarcinoma (LUAD), 46 squamous carcinomas (LUSC), and 24 other histology types. TMA sections were stained and scored for ITGA3 expression by immunohistochemistry (IHC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…More specifically in carcinomas, GalNAc-type O-glycosylation, is characterized by biosynthetically immature truncated glycans present on the cancer cell surface, which profoundly impact anti-tumor immune recognition. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…ABSTRACT: The treatment for locally advanced rectal carcinomas (LARC) is based on neoadjuvant chemoradiotherapy (nCRT) and surgery, which results in pathological complete response (pCR) in up to 30% of patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Survival remained poor (<60%) for rhabdomyosarcoma, lung, stomach, liver, bladder, and pancreatic carcinomas, among others. Mortality rates among male AYAs overall declined from 10.8 to 6.6 (AAPC: −1.64%) and from 14.4 to 10.1 per 100,000 person-years (AAPC: −1.81%) for female AYAs since 1990. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Excellent results were reported for squamocellular carcinomas (SCCs). Since the advent of the CROSS regimen, the results of surgery for esophageal adenocarcinomas (EAC) have cast some doubts about its efficacy on overall survival (OS) even in the presence of local response. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso